Fecal DNA Biomarkers for the Detection of Colorectal Neoplasia: Attractive, but Is It Feasible?-Reference-Cited by-同舟云学术

Fecal DNA Biomarkers for the Detection of Colorectal Neoplasia: Attractive, but Is It Feasible?

Published:2005-08-03 Issue:15 Volume:97 Page:1107-1109
ISSN:1460-2105
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Brenner Dean E.,Rennert Gad

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/97/15/1107/7686440/dji244.pdf

Reference28 articles.

1. Mandel JS, Bond JH, Bradley M, Snover DC, Church TR, Williams S, et al. Sensitivity, specificity, and positive predictivity of the Hemoccult test in screening for colorectal cancers. The University of Minnesota's Colon Cancer Control Study. Gastroenterology1989 ; 97 : 597 –600.

2. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study [published erratum appears in N Engl J Med 1993;329:672]. N Engl J Med1993 ; 328 : 1365 –71.

3. Kronborg O. Screening for colorectal cancer with Hemoccult-II in the average risk population. Gastroenterologie Clinique et Biologique1998 ; 22 (3 Suppl): S44 –8.

4. Kronborg O, Fenger C, Olsen J, Jorgensen O, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet1996 ; 348 : 1467 –71.

5. Rennert G. Fecal occult blood screening—trial evidence, practice and beyond. Recent Results Cancer Res2003 ; 163 : 248 –53; discussion 264–6.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chinese national clinical practice guidelines on prevention, diagnosis and treatment of early colorectal cancer;Chinese Medical Journal;2024-08-06

2. The Application Value of Syndecan-2 Gene Methylation for Colorectal Cancer Diagnosis: A Clinical Study and Meta-Analyses;Frontiers in Medicine;2022-03-15

3. SIGNIFICANCE OF E-CADHERIN AND VIMENTIN AS EPITHELIAL-MESENCHYMAL TRANSITION MARKERS IN COLORECTAL CARCINOMA PROGNOSIS;EXCLI J;2020

4. New Methylation Biomarker Panel for Early Diagnosis of Dysplasia or Cancer in High-Risk Inflammatory Bowel Disease Patients;Inflammatory Bowel Diseases;2018-08-07

5. THE ASSOCIATION OF VIMENTIN AND FIBRONECTIN GENE EXPRESSION WITH EPITHELIAL-MESENCHYMAL TRANSITION AND TUMOR MALIGNANCY IN COLORECTAL CARCINOMA;EXCLI J;2017